Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;43(1):31-45.
doi: 10.4093/dmj.2019.0011.

Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis

Yong Ho Lee  1   2 , Yongin Cho  1   2 , Byung Wan Lee  1   2 , Cheol Young Park  3 , Dae Ho Lee  4 , Bong Soo Cha  1   2 , Eun Jung Rhee  5
Affiliations
Review

Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis

Yong Ho Lee et al. Diabetes Metab J. 2019 Feb.

Erratum in

Abstract

Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders whose prevalence rates are expected to rise worldwide, corresponding to aging and increasingly obese populations. Compared to the general population (around 25%), 50% to 70% of people with diabetes have NAFLD, and NAFLD severity (including fibrosis) tends to be worsened by the presence of diabetes. NAFLD is considered an emerging risk factor for type 2 diabetes mellitus and a contributor to the development of chronic diabetes-related complications. This reciprocal relationship demonstrates the importance of confirming suspected NAFLD in patients with diabetes. Due to the invasive nature of liver biopsy to assess NAFLD status, various alternative non-invasive modalities have been developed and validated. Here, we summarized the epidemiology of NAFLD in patients with diabetes and reviewed currently available imaging modalities and biomarker-based prediction models for their ability to detect liver steatosis and/or fibrosis.

Keywords: Diabetes mellitus; Diagnosis; Epidemiology; Non-alcoholic fatty liver disease.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

    1. International Diabetes Federation: IDF Diabetes Atlas: Key Messages. [cited 2019 Feb 8]. Available from: http://diabetesatlas.org/key-messages.html.
    1. Korean Diabetes Association: Diabetes Fact Sheet in Korea 2018. [cited 2019 Feb 8]. Available from: http://www.diabetes.or.kr/pro/news/admin.php?category=A&code=admin&numbe....
    1. Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14:32–42. - PubMed
    1. Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66:1138–1153. - PubMed
    1. Younossi Z, Tacke F, Arrese M, Sharma BC, Mostafa I, Bugianesi E, Wong VW, Yilmaz Y, George J, Fan J, Vos MB. Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Hepatology. 2018 Sep 04; doi: 10.1002/hep.30251. [Epub] - DOI - PubMed

MeSH terms